Initial Experience With Everolimus-Eluting Bioresorbable Vascular Scaffolds for Treatment of Patients Presenting With Acute Myocardial Infarction: A Propensity-Matched Comparison to Metallic Drug Eluting Stents 18-Month Follow-Up of the BVS STEMI First Study

EuroIntervention - France
doi 10.4244/eijv12i1a6

Related search